+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Serologic response to treatment of infectious syphilis



Serologic response to treatment of infectious syphilis



Annals of Internal Medicine 114(12): 1005-1009



Objective: To evaluate the serologic response to treatment of patients with infectious symphilis. Design: Historical cohort study of all cases of infectious syphilis in Alberta from 1981 to 1987. Patients: A total of 1090 patients were entered; 857 with primary syphilis, 183 with secondary syphilis, and 50 with early latent disease. Two hundred and either patients were excluded who either were pregnant, had negative serologic results before treatment, had clinical relapse, were treatment failures, or were lost to follow-up. Interventions: All 882 evaluable patients were treated with a recommended antibiotic regimen for infectious syphilis and returned for re-assessment including repeat serologic testing. Measurements and Main Results: Seventy-two percent (95% CI, 66% to 77%) and 56% (CI, 43% to 70%) of patients with initial episodes of primary or secondary syphilis had seroreverted according to rapid plasma reagin (RPR) test results by 36 months. A 2- and 3-tube decline was seen by 6 and 12 months in primary and secondary syphilis. Early latent syphilis resulted in only a 2-tube decrease at 12 months. Serologic response was not affected by sex, age, race, or sexual orientation. Patients with their first infection were more likely to experience RPR seroreversal than those with repeat infections. The RPR reversal rates also depended on the pretreatment titer and stage of disease. At 36 months, 24% (CI, 20% to 28%) of patients had nonreactive fluorescent treponemal antibody absorption tests (FTA-Abs), and 13% (CI, 11% to 15%) had nonreactive microhemoglutination tests for Treponema pallidum (MHA-TP). Conclusions: Adequate therapeutic response for syphilis must be based on illness episode and the pretreatment RPR titer. Treponemal tests can demonstrate seroreversion after 36 months, and a negative treponemal tests does not rule out a past history of syphilis.

(PDF emailed within 0-6 h: $19.90)

Accession: 002219350

Download citation: RISBibTeXText

PMID: 2029095

DOI: 10.7326/0003-4819-114-12-1005


Related references

Studies on the comparative behavior of various serologic tests for syphilis. III. A report on return to seronegativity following successfully treated primary and secondary syphilis; with remarks on the serologic response of chronic biologic false positive reactors subsequently infected with syphilis. American Journal of Syphilis, Gonorrhea, and Venereal Diseases 37(6): 514-528, 1953

Treatment of syphilis and the serologic response. La Semana Medica 57(13): 479-484, 1950

Serologic response to treatment of syphilis in patients with HIV infection. Archives of Internal Medicine 156(3): 321-325, 1996

The sero-diagnosis of syphilis and the serologic response to treatment. Publ Health Lab 18(5): 111-115, 1960

Treatment of primary and secondary syphilis: serologic response. Journal of the American Academy of Dermatology 14(3): 487-491, 1986

Treatment of early latent syphilis under 1 year's duration: serologic response to treatment of 368 patients. Journal of the American Academy of Dermatology 15(5 Pt 1): 1059-1061, 1986

Factors determining serologic response to treatment in patients with syphilis. Clinical Infectious Diseases 49(10): 1505-1511, 2010

Effects of HIV infection on the serologic manifestations and response to treatment of syphilis. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 33(0): 334, 1993

The quantitatively titered serologic test in early syphilis and its response to treatment. Amer Jour Syphilis Gonorrhea And Venereal Dis 25(5): 566-582, 1941

First year serologic response to treatment for syphilis: A model for prediction of seroreversion. Statistics in Medicine 16(18): 2103-2115, 1997

Reinfection primary, secondary, and latent syphilis: the serologic response after treatment. Sexually Transmitted Diseases 7(3): 111-115, 1980

Reinfection primary and secondary syphilis: the post treatment serologic response. Sexually Transmitted Diseases 4(4): 132-134, 1977

Serologic response to treatment of late syphilis in hiv infected patients correlation with cd4 count. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : b148, 1992

Serologic response after antepartum secondary syphilis treatment with one vs two doses of benzathine penicillin. American Journal of Obstetrics & Gynecology 178(1 PART 2): S210, 1998

Assessment of lack of fit in simple linear regression: An application to serologic response to treatment for syphilis. Statistics in Medicine 16(4): 373-384, 1997